Cocrystal Pharma, Inc. (COCP)

Cocrystal Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	24	18	16	63	93	17
Market Cap Growth	-12.11%	10.34%	-74.94%	-32.06%	435.38%	-83.83%
Enterprise Value	4	-7	-21	5	61	11
PE Ratio	-	-0.97	-0.41	-4.47	-9.66	-0.36
PS Ratio	-	-	-	-	46.30	2.65
PB Ratio	1.06	0.66	0.40	0.82	1.78	0.68
P/FCF Ratio	-0.88	-1.19	-0.74	-4.96	-9.26	-10.20
P/OCF Ratio	-0.89	-1.19	-0.74	-4.98	-9.49	-11.14
EV/Sales Ratio	-	-	-	-	30.16	1.63
EV/EBITDA Ratio	0.37	0.41	0.55	-0.36	-6.53	-0.22
EV/EBIT Ratio	0.37	0.41	0.54	-0.36	-6.30	-0.22
EV/FCF Ratio	0.37	0.48	0.98	-0.40	-6.03	-6.27
Debt / Equity Ratio	0.08	0.07	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-0.12	-0.11	-0.01	-0.04	-0.06	-0.02
Debt / FCF Ratio	-0.11	-0.13	-0.01	-0.04	-0.06	-0.48
Quick Ratio	9.23	8.12	30.65	38.06	24.79	3.57
Current Ratio	10.30	8.92	33.04	38.40	25.05	3.62
Asset Turnover	0	0	0	0	0.04	0.10
Interest Coverage	-18.48	-27.10	-	-3545.25	-1205.00	-2534.21
Return on Equity (ROE)	-58.60%	-56.90%	-75.20%	-19.20%	-21.40%	-79.40%
Return on Assets (ROA)	-52.90%	-52.10%	-72.50%	-18.70%	-20.20%	-76.10%
Return on Capital (ROIC)	-72.14%	-65.73%	-97.40%	-18.21%	-18.05%	-182.49%
Earnings Yield	-69.77%	-102.64%	-244.58%	-22.39%	-10.35%	-276.57%
FCF Yield	-67.22%	-84.38%	-135.46%	-20.16%	-10.80%	-9.81%
Buyback Yield / Dilution	-24.94%	-18.52%	-10.58%	-60.04%	-73.32%	-13.75%
Total Shareholder Return	-24.94%	-18.52%	-10.58%	-60.04%	-73.32%	-13.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).